Abstract
This study aimed to assess the impact of testosterone undecylate on renal and hepatic functions by examining serum markers in obese and non-obese rats. The methodology involved treating these animals with testosterone undecylate or a control solution over a period of 28 days and analyzing serum samples for markers such as urea, creatinine, and liver enzymes. The results demonstrated no significant differences in creatinine, AST, ALT, GGT, ALP, and CK levels between the treated and control groups, suggesting that testosterone undecylate does not adversely affect renal or hepatic functions in the conditions tested. The study concludes that testosterone undecylate, within the administered doses, appears safe, presenting a favorable safety profile and good tolerability, making it a viable option for hormonal therapy in clinical and scientific settings.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
